Literature DB >> 21447123

Nomenclature and classification of vasculitis - update on the ACR/EULAR diagnosis and classification of vasculitis study (DCVAS).

R A Luqmani1, R Suppiah, P C Grayson, P A Merkel, R Watts.   

Abstract

Classification of vasculitis remains unsatisfactory. This is largely because the pathogenetic mechanisms of this family of related disorders have not been fully understood. Existing classification criteria are useful but limited. This has become more apparent with the advent of more effective and more specific therapies. A rational basis for classification could significantly improve our approach to treatment. The development of diagnostic criteria in vasculitis is an even greater challenge but may ultimately provide more useful for the non-specialist clinician. International efforts are underway to provide more effective classification and diagnostic criteria.
© 2011 The Authors;Clinical and Experimental Immunology © 2011 British Society for Immunology.

Entities:  

Mesh:

Year:  2011        PMID: 21447123      PMCID: PMC3095857          DOI: 10.1111/j.1365-2249.2011.04358.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  18 in total

1.  The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis.

Authors:  G G Hunder; D A Bloch; B A Michel; M B Stevens; W P Arend; L H Calabrese; S M Edworthy; A S Fauci; R Y Leavitt; J T Lie
Journal:  Arthritis Rheum       Date:  1990-08

2.  The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis.

Authors:  R Y Leavitt; A S Fauci; D A Bloch; B A Michel; G G Hunder; W P Arend; L H Calabrese; J F Fries; J T Lie; R W Lightfoot
Journal:  Arthritis Rheum       Date:  1990-08

3.  The American College of Rheumatology 1990 criteria for the classification of hypersensitivity vasculitis.

Authors:  L H Calabrese; B A Michel; D A Bloch; W P Arend; S M Edworthy; A S Fauci; J F Fries; G G Hunder; R Y Leavitt; J T Lie
Journal:  Arthritis Rheum       Date:  1990-08

4.  Systemic vasculitis--is it time to reclassify?

Authors:  Richard A Watts; Ravi Suppiah; Peter A Merkel; Raashid Luqmani
Journal:  Rheumatology (Oxford)       Date:  2010-07-20       Impact factor: 7.580

5.  The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis.

Authors:  W P Arend; B A Michel; D A Bloch; G G Hunder; L H Calabrese; S M Edworthy; A S Fauci; R Y Leavitt; J T Lie; R W Lightfoot
Journal:  Arthritis Rheum       Date:  1990-08

6.  Nomenclature and classification of vasculitis: plus ça change, plus c'est la même chose.

Authors:  J T Lie
Journal:  Arthritis Rheum       Date:  1994-02

Review 7.  Nomenclature of systemic vasculitides. Proposal of an international consensus conference.

Authors:  J C Jennette; R J Falk; K Andrassy; P A Bacon; J Churg; W L Gross; E C Hagen; G S Hoffman; G G Hunder; C G Kallenberg
Journal:  Arthritis Rheum       Date:  1994-02

8.  The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis).

Authors:  A T Masi; G G Hunder; J T Lie; B A Michel; D A Bloch; W P Arend; L H Calabrese; S M Edworthy; A S Fauci; R Y Leavitt
Journal:  Arthritis Rheum       Date:  1990-08

9.  The American College of Rheumatology 1990 criteria for the classification of Henoch-Schönlein purpura.

Authors:  J A Mills; B A Michel; D A Bloch; L H Calabrese; G G Hunder; W P Arend; S M Edworthy; A S Fauci; R Y Leavitt; J T Lie
Journal:  Arthritis Rheum       Date:  1990-08

10.  Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis.

Authors:  F J van der Woude; N Rasmussen; S Lobatto; A Wiik; H Permin; L A van Es; M van der Giessen; G K van der Hem; T H The
Journal:  Lancet       Date:  1985-02-23       Impact factor: 79.321

View more
  23 in total

1.  Spontaneous fusion between cancer cells and endothelial cells.

Authors:  K Mortensen; J Lichtenberg; P D Thomsen; L-I Larsson
Journal:  Cell Mol Life Sci       Date:  2004-08       Impact factor: 9.261

2.  Classic imaging for polyangitis nodosa.

Authors:  Jia-chuan Xiong; Zhao-xia He; Zhang-xue Hu
Journal:  Clin Exp Nephrol       Date:  2013-09-10       Impact factor: 2.801

Review 3.  Intravascular immunity as a key to systemic vasculitis: a work in progress, gaining momentum.

Authors:  G A Ramirez; N Maugeri; M G Sabbadini; P Rovere-Querini; A A Manfredi
Journal:  Clin Exp Immunol       Date:  2014-02       Impact factor: 4.330

Review 4.  Clinical Approach to Diagnosis and Therapy of Polyarteritis Nodosa.

Authors:  Alojzija Hočevar; Matija Tomšič; Katja Perdan Pirkmajer
Journal:  Curr Rheumatol Rep       Date:  2021-02-10       Impact factor: 4.592

5.  Broadening the translational immunology landscape.

Authors:  M Peakman
Journal:  Clin Exp Immunol       Date:  2012-12       Impact factor: 4.330

Review 6.  Localized, single-organ vasculitis: clinical presentation and management.

Authors:  Yemil Atisha-Fregoso; Andrea Hinojosa-Azaola; Jorge Alcocer-Varela
Journal:  Clin Rheumatol       Date:  2012-08-24       Impact factor: 2.980

Review 7.  [Skin diseases due to systemic vasculitides and vasculopathies].

Authors:  S Volc; J C Maier; M Röcken
Journal:  Hautarzt       Date:  2016-12       Impact factor: 0.751

8.  Granulomatosis with polyangiitis (Wegener's) presenting as the right ventricular masses: A case report and review of the literature.

Authors:  Mojgan Mortazavi; Hamid Nasri
Journal:  J Nephropathol       Date:  2012-04-05

Review 9.  Diagnostic accuracy of 18F-FDG PET or PET/CT for large vessel vasculitis : A meta-analysis.

Authors:  Y H Lee; S J Choi; J D Ji; G G Song
Journal:  Z Rheumatol       Date:  2016-11       Impact factor: 1.372

10.  The complexity of classifying ANCA-associated small-vessel vasculitis in actual clinical practice: data from a multicenter retrospective survey.

Authors:  Luis Corral-Gudino; Elvira González-Vázquez; Ismael Calero-Paniagua; Laura Pérez-Garrido; Ivan Cusacovich; Alicia Rivas-Lamazares; Alba Quesada-Moreno; Ana González-Fernández; Damian Mora-Peña; Jose Luis Lerma-Márquez; Javier Del-Pino-Montes
Journal:  Rheumatol Int       Date:  2019-08-05       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.